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This work studies the structure-function relationships of Asn”‘. a restdue srtuated in the GTP binding pocket of elongation factor Tu (EF-Tu). 
For this purpose we constructed EF-TuN135DID138N and assayed its reactrvity towards various purine nucleottdes. We found that EF-TuNl35D/ 
D138N had no functional effect with GTP, ATP, XTP and isoGTP. The lack of a productrve mteractron with )soGTP shows that the AsnlZ’ 
side-chain does not recogmze the exocyclic keto group of the guanine base. However, EF-TuN 135D/D138N. whose native confonnatron is stabilized 
by either elongation factor Ts or kirromycm, was able to support the enzymatic binding of aa-tRNA to the ribosome in the absence of any nucleotide, 
when in complex with the antrbiotrc. Taken together, these results show that Asn’“’ is important for the correct foldmg of the nucleotide bmding 
site and that EF-Tuktrromycm can medrate the binding of aa-tRNA to the mRNA-programmed ribosomes independently of the nattve conforma- 
tron of this sue. 
EF-Tu; Folding of GTP-bmding pocket; Base recognition; iJoGTP 
1. INTRODUCTION 
A large number of cell pathways are regulated by 
guanine nucleotide binding proteins [1,2]. So far the 
three-dimensional structure (3D) of only two of these 
proteins have been elucidated: elongation factor Tu 
(EF-Tu), an essential component of bacterial protein 
biosynthesis, and c-H-ras ~21, a regulatory element of 
growth control and cell division in mammals. As for all 
GTP-binding proteins, the active form of EF-Tu is the 
complex with GTP, that is characterized by a high affin- 
ity for aa-tRNA and ribosomes, whereas the complex 
with GDP interacts productively only with elongation 
factor Ts (EF-Ts). After the hydrolysis of GTP, that 
follows the interaction between the aa-tRNA.EF- 
Tu.GTP complex and the mRNA-programmed ribo- 
some, the resulting EF-Tu.GDP leaves the ribosome 
and is regenerated to the active form via a GDP to GTP 
exchange reaction specifically stimulated by EF-Ts 
[3,4]. The affinity of EF-Tu for GTP. which is much 
lower than that for GDP, is strongly increased by the 
binding of aa-tRNA [5]. EF-Tu binds guanine nucleo- 
tides in a highly specific manner. The replacement of 
guanine with hypoxanthine or xanthine impairs the 
binding of the nucleotide by two orders of magnitude; 
and with adenine or cytosine by four orders [3,6]. The 
3D model of a nicked EF-Tu.GDP molecule at medium 
resolution (2.6 A) suggests that the aminogroup N(2) of 
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the base forms a strong hydrogen bond with Asp138 of 
EF-Tu [7,8]. similarly to the corresponding residue 
(Asp’19) in the 3D model of c-H-ras p21 at 1.35 A reso- 
lution [9]. Raman spectroscopy confirmed the existence 
of this hydrogen bond [lo]. Functional data have sup- 
ported this possibility; in 1987 Hwang and Miller [l l] 
and recently Weijland and Parmeggiani [12] observed 
that EF-TuD138N recognizes XTP with an affinity 
comparable to that of wild-type EF-Tu (EF-Tu wt) for 
GTP. Less clear is the situation concerning the exocyclic 
O(6) of the base. In 1985 LaCour et al. [7] suggested that 
the side-chain amino group of Asn13’ could form a hy- 
drogen bond with O(6) of guanine. For Jurnak [8] this 
residue was situated directly over the plane of the gua- 
nine ring but a weak interaction with this base was not 
excluded. The recently refined model of EF-Tu.GDP 
[13] describes for the amino side-chain of Asn13’ the 
hydrogen bonds with O(6) and N(7) but also mentions, 
as a more probable alternative, a hydrogen bond with 
the main-chain (MC) carbonyl group of His”. a residue 
that is part of the consensus element ‘8GXXXXGK 
involved in the phosphate binding. The latter situation 
is similar to the p21 model of Pai et al. [9]. In ~21, the 
guanine O(6) forms a hydrogen bond with the MC car- 
bony1 of Ala”” (Ala”’ m EF-Tu). excluding a hydrogen 
bond with Asnli6 (Asn”S in EF-Tu), a residue that inter- 
acts weakly with the N(7) of the base and ties together 
three fundamental consensus sequence elements 
(‘“GXXXXB; “6mXD and lJ’s) essential for a 
correct architecture of the GTP binding pocket. Curi- 
334 
Volume 330. number 3 FEBS LETTERS September 1993 
ously, in a p21.GDP model at 2.5 A Milburn et al. [14] 
depict a hydrogen bond between Asn’i6 side-chain and 
O(6) of the base. 
In the actual state of our 3D knowledge, substitution 
of both Asn13’ and Asp13* would define the role of 
Asn’3s in the nucleotide binding site of EF-Tu and une- 
quivocally elucidate the participation of the side-chain 
nitrogen of Asn13’ in the recognition of the base. Indeed, 
should Asn’35 interact with guanine O(6), EF- 
TuN135D/D138N would be expected to interact pro- 
ductively with isoGTP, an analogue of GTP in which 
the exocyclic nitrogen and oxygen of the base are substi- 
tuted by an oxygen and nitrogen, respectively. The ob- 
servation that EF-TuD138N is as active as EF-Tu wt, 
if GTP is replaced with XTP [l l] supports this assump- 
tion. It was moreover interesting to test the ability of 
EF-TuN135D/D138N to interact with the EF-Tu li- 
gands. 
2. MATERIALS AND METHODS 
EF-TuNl35D/Dl38N was constructed by site-dtrected muta- 
genesis of the tufA gene cloned in pEMBL9’. The ohgodeoxynucleo- 
tide GTGTTCCTGGACAAATG was used to substitute Asn”’ with 
Asp in EF-TuDl38N [12]. The modified tufA was overexpressed via 
pTTQl8 under control of the tuc promotor m the RecA. E. cd stram 
PM1455, containing only one active rufA gene encoding a kirromycin- 
resistant product [15] EF-Tu Nl35D/Dl38N was purified according 
to the method utilizmg the antibiotic ktrromycm [12]. 
The reactivities of EF-Tu wt and Nl35DIDl38N to GTP. ATP. 
XTP and isoGTP or the EF-Tu-dependent binding of Phe-tRNAPh’ 
to the mRNA-programmed ribosome were assayed by retention of the 
labelled compound on nitrocellulose filters [12]. XTP, GTP, ITP and 
ATP were obtained from Sigma. The isoGTP was synthesized by 
radiation of ATP wtth a Hanau Lamp with Heliostl filter, 1 = 245 nm 
[17]. Conversion of ATP to isoGTP takes place via l-oxide ATP. In 
the last step isoGTP was purified on a nucleosil 5Cl8 column using 
a linear gradtent ranging from 5 to 25% acetonitrile in trtethylammo- 
nium acetate. The composttion was analyzed by the absorption spec- 
trum and by ‘H, “C, and “P NMR. The NMR spectra are shown in 
Fig. 1. [y-“P] XTP and [y-32P]~soGTP were synthettsed by the method 
of Glynn and Chappell [16], [y-3’P]GTP and [y-“P]ATP were from 
Amersham. [‘4C]Phe-tRNAPh’ was prepared as reported [18] 
The EF-Tu-dependent hydrolysis of the nucleoside triphosphates 
was measured by the charcoal method and protein concentrations 
were determined by the Bradford method using bovine serum albumin 
as a standard [19]. 
3. RESULTS 
Fig. 2 shows the structure of the nucleotide bases 
(adenine, guanine, isoguanine, hypoxanthine and xan- 
thine) used or mentioned in this work and Fig. 3 the 
interactions involved in the recognition of the exocyclic 
groups of the base in the case of EF-Tu wt, EF- 
TuN135D/D138N and EF-TuN135D. as derived from 
the most recent model of Kjeldgaard and Nyborg [13]. 
The procedure for the isolation of EF-TuN135DI 
D138N took into consideration its inability to interact 
with GTP [12] and the very low concentration, if any. 
of XTP in the bacterial cell. Nucleotide-free EF-Tu wt 
is very unstable but it is stabilized by EF-Ts or kirromy- 
tin, two ligands behaving as chaperone-like molecules 
Fig 1. , , “C- ‘H- “P-NMR spectra of rsoGTP. (A) “C-NMR 75MHz: (DzO) 6 = 65.95(C-5’): 71 08(C-3’); 75.OO(C-2’); 84.59(C-4’): 86.75(C-1’); 
llO.l8(C-5): 139.44(C-8); 151.6(C-4); 154.8(C-6); 158.O(C-2). 
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Fig. I (contmued) (B) ‘H-NMR 30OMHz: (DzO) 6 = 5.87(d. lH, J,,> = 6.5 Hz, H-l), 8.2(s, lH, H-8). (C) “P-NMR 121MHz: (D,O) d(PO,H, as 
reference) = -9 2(d. 1P. Py, Jpympo = 20.6 Hz); -10,89(d,lP, Pa, JPa-PB = 20.6 Hz, Jpo_py = 0 Hz); -22.55(d, lP, PB, J,_, = Jpa+ = 20.6 Hz). 
in preserving the active conformation of EF-Tu [20]. 
Therefore for the purification of EF-TuN135D/D 138N 
we applied the method using EF-Ts and kirromycin [2 1, 
221, that allows the protection of EF-Tu against denatu- 
ration from the overproduction in the cell through the 
purification procedure and its characterization. The sol- 
uble plasmid-borne kirromycin-bound EF-TuNI 3.5Dl 
D138N was fully separated from the chromosomal kir- 
romycin-resistant EF-TuAr on DEAE chromatogra- 
phy, and then freed from the antibiotic by dialysis in the 
presence of EF-Ts [21, 221. Kirromycin- or EF-Ts- 
bound EF-TuN135DID138N was stable for at least one 
year when kept at -20 “C in 50 mM Tris-HCl buffer, 
pH 7.6,70 mM NH&l, 7 mM MgCl,, 1 mM dithiothre- 
itol and 50% glycerol. The yield was less than 1 mg per 
20 g of cells. 
The experimental results showed that neither GTP, 
ATP, XTP or, most importantly, isoGTP, up to 10 ,uM 
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Adenlne 
Fig. 2. The structure of the bases of the nucleotides used for this study. 
concentration, could be bound to EF-TuN135D/ 
D138N in detectable amounts, even if kirromycin or 
EF-Ts were present (not illustrated). The former ligand 
is known to increase the affinity of EF-Tu for GTP by 
more than two orders of magnitude [5]. In line with 
these experiments, no hydrolytic activity dependent on 
EF-TuN135D/D138N could be detected either using 
[Y-~~P]ATP, [y-32P]XTP, [Y-~~P]GTP or [y-3’P]isoGTP, 
even in the presence of kirromycin or the ribosome, two 
ligands that are stimulators of the intrinsic GTPase ac- 
tivity of EF-Tu [23]. The absence of any productive 
interaction with i.soGTP strongly suggests the lack of a 
hydrogen bond interaction between Asn’35 side chain 
and O(6) of the base, at least of a strength comparable 
to that between Asp13* and the exocyclic amino group 
[7-91. To test the interaction with other ligands, we also 
analyzed whether this mutant could sustain the Phe- 
tRNAPh’ binding to poly(U)-programmed ribosomes, a 
sensitive test, since aa-tRNA strongly stabilizes the EF- 
Tu wt-GTP complex [5]. None of the nucleotides used 
was capable of inducing any EF-Tu-dependent binding 
of Phe-tRNAPh’ to the ribosome, except for GTP in the 
case of EF-Tu wt. as expected (Fig. 4A). Remarkably, 
in the presence of kirromycin the enzymatic binding 
could take place with both EF-Tu species in the absence 
of any nucleotide (Fig. 4B). It is known that kirromycin 
induces a GTP-like conformation of EF-Tu, enabling 
the enzymatic binding of Phe-tRNAPh’ to the ribosome 
in the absence of GTP and even in the presence of GDP 
[24,25]. The observation that kirromycin can induce the 
same binding with either EF-TuN135D/D138N or EF- 
Tu wt proves that the lack of interaction with isoGTP 
and XTP was a consequence of a disordered architec- 
ture of the EF_TuN135D/D138N binding pocket and 
not of a denaturation of the whole molecule. 
4. DISCUSSION 
The lack of a productive interaction between EF- 
TuNl35D/N 138N and the various nucleotides supports 
a 3D model in which, like the corresponding residue in 
~21, Asn13’ is not involved in the recognition of the O(6) 
group of the base. This residue is crucial for an active 
conformation of the nucleotide binding pocket, since 
the replacement of Asn135 with Asp on EF-TuD138N 
completely abolishes any response to XTP. Moreover. 
it is known that substitution of Asn’3s(+D) alone in- 
duces toxic effects on cell growth [26]. In EF-Tu wt (Fig. 
3) Asn’“’ connects the loops 19-22 and 173-175 by 
hydrogen bonds. This interaction takes place between 
His’2-OMC (acceptor)...Asn135-NH, (donor) and 
Asn135-Opl (acceptor)...Ala’7”-NH (donor). The substi- 
tution with Asp 135, in which both Oal and Op2 are 
acceptors, abolishes the hydrogen bond between His” 
and AsP’~‘, indicating that this hydrogen bond is essen- 
tial for a correct folding of the nucleotide binding 
pocket. 
As derived from the p21 model other residues, such 
as Ala’74 and perhaps Ser17”. are likely to be determi- 
nants for the O(6) recognition. That O(6) is very impor- 
tant for the EF-Tu recognition of guanine is supported 
by the observations of Wittinghofer [6] and Eccleston 
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Fig. 3. A diagram representing the hydrogen bond interactions of 
EF-Tu wt with guanine (A), EF-TuD138N with xanthine (B), and 
EF-TuN135D/D138N with isoguanine (C), according the refined 
model of Kjeldgaard and Nyborg [13]. 
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Fig. 4. EF-Tu or EF-TuN 135DIDl38N mediated bindmg of Phe-tRNAPhc to the ribosome in the presence of GTP (A) or kirromycin (B). The binding 
was performed by adding to a 30 ~1 reaction mixture (40 pmol N-AcetylPhe-tRNAPheribosome.Poly(U) complex), 20/tlof a solution containing 
20 pmol [‘HIPhe-tRNAPh’ ( 1 Ci/mmol), 20 pmol weld-type (0) or mutant (4) EF-Tu , 20 pmol EF-Ts. and 10 PM GTP (A) or 1 PM kirromycin 
(B). The bmding experiments were performed at 0°C. At the time intervals indicated samples (9 ~1) were taken and pipetted onto nitrocellulose 
filters, EF-Tu-Independent (nonenzymatic) binding (m). was carried out as above except that EF-Tu was omitted. 
[27] that in p21 replacement of O(6) by a sulphur re- 
duces the affinity towards the nucleotide by two orders 
of magnitude and its replacement by a hydrogen com- 
pletely abolishes the binding of the nucleotide. Moreo- 
ver EF-Tu D138N cannot bind isoGTP. whereas EF- 
TuD138N is fully active in the presence of XTP. In line 
with this, though both ITP or XTP can bind to EF-Tu 
wt with an affinity loo-times lower than GTP [3,6], 
EF-Tu D138N was unable to perform protein biosyn- 
thesis in the presence of ITP (A. Weijland, unpublished 
results). Therefore for an efficient activity of EF-Tu the 
interaction with both exocyclic groups is a prerequisite. 
Interestingly, despite the anomalous conformation of 
the nucleotide binding pocket induced by the substitu- 
tion of Asn’““, kirromycin is still able to transmit the 
signal inducing an active GTP-like conformation of EF- 
Tu, capable of mediating the binding of aa-tRNA to the 
A site of mRNA-programmed ribosomes. This shows 
that the mechanism of action of this antibiotic is not 
conditioned by a correct conformation of the nucleotide 
binding pocket, but it can propagate via other struc- 
tures and influence the overall conformation of the EF- 
Tu molecule. 
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